ASTRAZENECA is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as much as $15 billion, Bloomberg News reported on Thursday, citing people familiar with ...

A GoFundMe campaign launched for Aya, a Toronto baker and pastry chef known for her talent and commitment to her craft, has ...

The first half of 2025 has been marked by a surge in strategic activity across the global healthcare, life sciences, and ...